{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T13:51:12Z","timestamp":1783432272678,"version":"3.54.6"},"reference-count":23,"publisher":"Oxford University Press (OUP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,2,1]]},"DOI":"10.1093\/jac\/dki441","type":"journal-article","created":{"date-parts":[[2005,12,14]],"date-time":"2005-12-14T02:38:37Z","timestamp":1134527917000},"page":"230-235","source":"Crossref","is-referenced-by-count":54,"title":["Anti-inflammatory effects of moxifloxacin on IL-8, IL-1\u03b2 and TNF-\u03b1 secretion and NF\u03baB and MAP-kinase activation in human monocytes stimulated with Aspergillus fumigatus"],"prefix":"10.1093","volume":"57","author":[{"given":"Itamar","family":"Shalit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Drora","family":"Halperin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debby","family":"Haite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avital","family":"Levitov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Romano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nir","family":"Osherov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ina","family":"Fabian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2005,12,13]]},"reference":[{"key":"key\n\t\t\t\t20171010205237_B1","doi-asserted-by":"crossref","unstructured":"Lin SJ, Schranz J, Teutsch SM. Aspergillosis case-fatality rate: systematic review of the literature. Clin Infect Dis2001; 32: 358\u201366.","DOI":"10.1086\/318483"},{"key":"key\n\t\t\t\t20171010205237_B2","doi-asserted-by":"crossref","unstructured":"Herbrecht R, Denning DW, Paterson TF et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis N Engl J Med2002; 347: 408\u201315.","DOI":"10.1056\/NEJMoa020191"},{"key":"key\n\t\t\t\t20171010205237_B3","doi-asserted-by":"crossref","unstructured":"Maertens J, Raad I, Petrikkos G et al. Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy. Clin Infect Dis2004; 39: 1536\u201371.","DOI":"10.1086\/423381"},{"key":"key\n\t\t\t\t20171010205237_B4","doi-asserted-by":"crossref","unstructured":"Shalit I, Horev-Azaria L, Fabian I et al. Immunomodulatory and protective effects of moxifloxacin against Candida albicans-induced bronchopneumonia in mice injected with cyclophosphamide. Antimicrob Agents Chemother2002; 46: 2442\u20139.","DOI":"10.1128\/AAC.46.8.2442-2449.2002"},{"key":"key\n\t\t\t\t20171010205237_B5","unstructured":"Blau H, Fabian I, Kletter Y et al. Protective immunomodulation by moxifloxacin against Candida albicans lung infection in cyclophosphamide treated mice: suppression of TNF-\u03b1, IL-8 and NF-kB activation. In: Abstracts of the 2002 Meeting of the American Thoracic Society, Atlanta, GA, 2002. Abstract B-59. American Thoracic Society, New York, NY, USA."},{"key":"key\n\t\t\t\t20171010205237_B6","doi-asserted-by":"crossref","unstructured":"Weiss T, Shalit I, Blau H et al. Anti-inflammatory effects of moxifloxacin on activated human monocytic cells: inhibition of NF-\u03baB and mitogen-activated protein kinase activation and of synthesis of proinflammatory cytokines. Antimicrob Agents Chemother2004; 48: 1974\u201382.","DOI":"10.1128\/AAC.48.6.1974-1982.2004"},{"key":"key\n\t\t\t\t20171010205237_B7","doi-asserted-by":"crossref","unstructured":"Nessa K, Jarstrand C, Johansson A et al. In vitro interaction of alveolar macrophages and Aspergillus fumigatus. Environ Res1997; 74: 54\u201360.","DOI":"10.1006\/enrs.1997.3730"},{"key":"key\n\t\t\t\t20171010205237_B8","doi-asserted-by":"crossref","unstructured":"Chilvers ER, Spreadbury CL, Cohen J. Bronchoalveolar lavage in an immunosuppressed rabbit model of invasive aspergillosis. Mycopathologia1989; 108: 163\u201371.","DOI":"10.1007\/BF00436221"},{"key":"key\n\t\t\t\t20171010205237_B9","doi-asserted-by":"crossref","unstructured":"Yekutiel A, Shalit I, Shadkhan Y et al. In vitro activity of caspofungin combined with sulfamethoxazole against clinical isolates of Aspergillus spp. Antimicrob Agents Chemother2004; 48: 3279\u201383.","DOI":"10.1128\/AAC.48.9.3279-3283.2004"},{"key":"key\n\t\t\t\t20171010205237_B10","doi-asserted-by":"crossref","unstructured":"Wang JE, Warris A, Ellingsen EA et al. Involvement of CD14 and Toll-like receptors in activation of human monocytes by Aspergillus fumigatus hyphae. Infect Immun2001; 69: 2402\u20136.","DOI":"10.1128\/IAI.69.4.2402-2406.2001"},{"key":"key\n\t\t\t\t20171010205237_B11","doi-asserted-by":"crossref","unstructured":"Mambula SS, Sau K, Henneke P et al. Toll-like receptor (TLR) signaling in response to Aspergillus fumigatus. J Biol Chem2002; 277: 39320\u201326.","DOI":"10.1074\/jbc.M201683200"},{"key":"key\n\t\t\t\t20171010205237_B12","doi-asserted-by":"crossref","unstructured":"Roilides E, Holmes A, Blake C et al. Antifungal activity of elutriated human monocytes against Aspergillus fumigatus hyphae: enhancement by granulocyte-macrophage colony-stimulating factor and interferon-\u03b3. J Infect Dis1994; 170: 894\u20139.","DOI":"10.1093\/infdis\/170.4.894"},{"key":"key\n\t\t\t\t20171010205237_B13","doi-asserted-by":"crossref","unstructured":"Mehrad B, Strieter RM, Standiford TJ. Role of TNF-\u03b1 in pulmonary host defense in murine invasive aspergillosis. J Immunol1999; 162:1633\u201340.","DOI":"10.4049\/jimmunol.162.3.1633"},{"key":"key\n\t\t\t\t20171010205237_B14","doi-asserted-by":"crossref","unstructured":"Roilides E, Dimitriadou A, Kadiltsoglou I et al. IL-10 exerts suppressive and enhancing effects on anti-fungal activity of mononuclear phagocytes against Aspergillus fumigatus. J Immunol1997; 158: 322\u20139.","DOI":"10.4049\/jimmunol.158.1.322"},{"key":"key\n\t\t\t\t20171010205237_B15","doi-asserted-by":"crossref","unstructured":"Warris A, Netea MG, Wang JE et al. Cytokine release in healthy donors and patients with chronic granulomatous disease upon stimulation with Aspergillus fumigatus. Scand J Infect Dis2003; 35: 482\u20137.","DOI":"10.1080\/00365540310013009"},{"key":"key\n\t\t\t\t20171010205237_B16","doi-asserted-by":"crossref","unstructured":"Soman A, Honeybourne D, Andrews J et al. Concentrations of moxifloxacin in serum and pulmonary compartments following a single 400 mg oral dose in patients undergoing fibre-optic bronchoscopy. J Antimicrob Chemother1999; 44: 835\u20138.","DOI":"10.1093\/jac\/44.6.835"},{"key":"key\n\t\t\t\t20171010205237_B17","doi-asserted-by":"crossref","unstructured":"Dalhoff A, Shalit I. Immunomodulatory effects of quinolones. Lancet Infect Dis2003; 3: 359\u201371.","DOI":"10.1016\/S1473-3099(03)00658-3"},{"key":"key\n\t\t\t\t20171010205237_B18","doi-asserted-by":"crossref","unstructured":"Khan AA, Slifer TR, Araujo FG et al. Protection against lipopolysaccharide-induced death by fluoroquinolones. Antimicrob Agents Chemother2000; 44: 3169\u201373.","DOI":"10.1128\/AAC.44.11.3169-3173.2000"},{"key":"key\n\t\t\t\t20171010205237_B19","doi-asserted-by":"crossref","unstructured":"Purswani MU, Eckert SJ, Arora HK et al. Effect of ciprofloxacin on lethal and sublethal challenge with endotoxin and on early cytokine response in a murine in vivo model. J Antimicrob Chemother2002; 50: 51\u20138.","DOI":"10.1093\/jac\/dkf091"},{"key":"key\n\t\t\t\t20171010205237_B20","unstructured":"Breban M, Fournier C, Gougerot-Pocidalo MA et al. Protective effects of ciprofloxacin against type II collagen induced arthritis in rats. J Rheumatol1992; 19: 216\u201322."},{"key":"key\n\t\t\t\t20171010205237_B21","doi-asserted-by":"crossref","unstructured":"Uriarte SM, Molestina RE, Miller RD et al. Effects of fluoroquinolones on the migration of human phagocytes through Chlamydia pneumoniae-infected and tumor necrosis factor alpha-stimulated endothelial cells. Antimicrob Agents Chemother2004; 48: 2538\u201343.","DOI":"10.1128\/AAC.48.7.2538-2543.2004"},{"key":"key\n\t\t\t\t20171010205237_B22","doi-asserted-by":"crossref","unstructured":"Bucaneve G, Micozzi A, Menicheti F et al. Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia. N Engl J Med2005; 353: 977\u201387.","DOI":"10.1056\/NEJMoa044097"},{"key":"key\n\t\t\t\t20171010205237_B23","doi-asserted-by":"crossref","unstructured":"Cullen M, Steven N, Billingham L et al. Antibacterial prophylaxis after chemotherapy for solid tumors and lymphomas. N Engl J Med2005; 353: 988\u201398.","DOI":"10.1056\/NEJMoa050078"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/57\/2\/230\/2407669\/dki441.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T22:02:12Z","timestamp":1683324132000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/jac\/article\/57\/2\/230\/804615\/Antiinflammatory-effects-of-moxifloxacin-on-IL8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12,13]]},"references-count":23,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2005,12,13]]},"published-print":{"date-parts":[[2006,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dki441","relation":{},"ISSN":["1460-2091","0305-7453"],"issn-type":[{"value":"1460-2091","type":"electronic"},{"value":"0305-7453","type":"print"}],"subject":[],"published-other":{"date-parts":[[2006,2]]},"published":{"date-parts":[[2005,12,13]]}}}